CL2004000471A1 - Composicion farmaceutica que comprende un agente antibacteriano y un segundo agente seleccionado de antiinflamatorios, analgesicos y antipireticos y un vehiculo que comprende un aceite anfipatico, cera microcristalina y un excipiente no acuoso; su us - Google Patents

Composicion farmaceutica que comprende un agente antibacteriano y un segundo agente seleccionado de antiinflamatorios, analgesicos y antipireticos y un vehiculo que comprende un aceite anfipatico, cera microcristalina y un excipiente no acuoso; su us

Info

Publication number
CL2004000471A1
CL2004000471A1 CL200400471A CL2004000471A CL2004000471A1 CL 2004000471 A1 CL2004000471 A1 CL 2004000471A1 CL 200400471 A CL200400471 A CL 200400471A CL 2004000471 A CL2004000471 A CL 2004000471A CL 2004000471 A1 CL2004000471 A1 CL 2004000471A1
Authority
CL
Chile
Prior art keywords
antipiretic
amphipatic
analgesic
inflammatory
oil
Prior art date
Application number
CL200400471A
Other languages
English (en)
Inventor
J Britten John W Burns J Nancy
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of CL2004000471A1 publication Critical patent/CL2004000471A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CL200400471A 2003-03-20 2004-03-09 Composicion farmaceutica que comprende un agente antibacteriano y un segundo agente seleccionado de antiinflamatorios, analgesicos y antipireticos y un vehiculo que comprende un aceite anfipatico, cera microcristalina y un excipiente no acuoso; su us CL2004000471A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45620103P 2003-03-20 2003-03-20

Publications (1)

Publication Number Publication Date
CL2004000471A1 true CL2004000471A1 (es) 2005-04-22

Family

ID=33030090

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400471A CL2004000471A1 (es) 2003-03-20 2004-03-09 Composicion farmaceutica que comprende un agente antibacteriano y un segundo agente seleccionado de antiinflamatorios, analgesicos y antipireticos y un vehiculo que comprende un aceite anfipatico, cera microcristalina y un excipiente no acuoso; su us

Country Status (19)

Country Link
US (1) US20040214753A1 (es)
EP (1) EP1608406A1 (es)
JP (1) JP2006520778A (es)
KR (1) KR100765614B1 (es)
CN (1) CN1761486A (es)
AR (1) AR043651A1 (es)
AU (1) AU2004222518A1 (es)
BR (1) BRPI0408559A (es)
CA (1) CA2519589A1 (es)
CL (1) CL2004000471A1 (es)
CO (1) CO5611165A2 (es)
MX (1) MXPA05010019A (es)
NO (1) NO20054777L (es)
NZ (1) NZ541780A (es)
RU (1) RU2321423C2 (es)
TW (1) TWI265809B (es)
UY (1) UY28236A1 (es)
WO (1) WO2004082719A1 (es)
ZA (1) ZA200506531B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
MXPA05005995A (es) * 2002-12-02 2006-01-27 Byocoat Entpr Inc Composicion y metodo para tratar una enfermedad fungica en una planta.
AU2004218353C1 (en) 2003-03-05 2011-02-24 Byocoat Enterprises, Inc. Antimicrobial solution and process
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE602005002742T2 (de) * 2004-04-22 2008-01-24 Pfizer Products Inc., Groton Verfahren zur stabilisierung von ungeordnetem cefovecin-natriumsalz
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
US7858115B2 (en) 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
US20070264296A1 (en) * 2006-05-10 2007-11-15 Myntti Matthew F Biofilm extracellular polysachharide solvating system
US7976873B2 (en) 2006-05-10 2011-07-12 Medtronic Xomed, Inc. Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
US7993675B2 (en) 2006-05-10 2011-08-09 Medtronic Xomed, Inc. Solvating system and sealant for medical use in the sinuses and nasal passages
US7959943B2 (en) 2006-05-10 2011-06-14 Medtronics Xomed, Inc. Solvating system and sealant for medical use in the middle or inner ear
NZ574396A (en) * 2006-07-10 2012-07-27 Advanced Enzyme Technologies Ltd Compositions for prevention and treatment of mastitis and metritis comprising a combination of serratiopeptidase, lysozymes, oscium sanctum, or azardirecta indica
WO2008097317A1 (en) * 2007-02-08 2008-08-14 Medtronic Xomed, Inc. Solvating system and sealant for medical use
US8088095B2 (en) 2007-02-08 2012-01-03 Medtronic Xomed, Inc. Polymeric sealant for medical use
BRPI0700969A (pt) * 2007-03-22 2008-11-04 Ouro Fino Participacoes E Empr composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
US20100298386A1 (en) * 2007-10-03 2010-11-25 Burwell Steven R Compositions and methods for treating mastitis
RU2513142C2 (ru) 2008-06-12 2014-04-20 Медтроник Ксомед Инк. Способ лечения хронических ран
US8318817B2 (en) * 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
WO2010042427A2 (en) 2008-10-06 2010-04-15 Microbial Defense Systems, Llc Antimicrobial composition and methods of making and using same
CN101953784B (zh) * 2009-07-16 2012-02-08 中国农业大学 含阿莫西林、硫酸粘菌素和***龙的兽用混悬液及其制备方法
IN2012DN03157A (es) 2009-10-12 2015-09-18 Boehringer Ingelheim Vetmed
AU2010347598B2 (en) 2010-03-03 2014-11-27 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2706845B1 (en) 2011-05-10 2021-06-23 Next Science IP Holdings Pty Ltd Antimicrobial solid and methods of making and using same
BRPI1103782A2 (pt) * 2011-08-19 2013-07-30 Eurofarma Lab Ltda produto veterinÁrio para tratamento de mastite, pre composiÇço antibiàtica a anti inflamatària, kit, mÉtodo de preparaÇço uso e mÉtodo de tratamento de mastite
CN102784161A (zh) * 2012-08-01 2012-11-21 张吉川 一种治疗急慢性中耳炎的特效滴耳液
CA2919892C (en) 2013-08-12 2019-06-18 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
CN104825474B (zh) * 2015-04-30 2018-02-06 中国农业科学院兰州畜牧与兽药研究所 一种治疗动物体表损伤的药物组方及其制备工艺
ES2949838T3 (es) * 2015-05-06 2023-10-03 Zoetis Services Llc Formulación de hidrogel con adherencia leve
US10434097B1 (en) 2015-09-14 2019-10-08 Gateway Biotechnology, Inc. Methods and compositions for treating hearing disorders
JP7217700B2 (ja) 2016-09-13 2023-02-03 アラーガン、インコーポレイテッド 安定化非タンパク質クロストリジウム毒素組成物
CN107252441A (zh) * 2017-08-07 2017-10-17 咸阳职业技术学院 一种治疗奶牛乳腺炎的药物组合物及其制备方法
US11918653B2 (en) * 2017-12-22 2024-03-05 Dompé Farmaceutici S.P.A. Triglyceride otic formulations and uses thereof
WO2020181024A1 (en) * 2019-03-06 2020-09-10 Zoetis Services Llc Ready-to-use injectable formulations
JP2022546036A (ja) * 2019-08-27 2022-11-02 ケーアイ ファーマシューティカルズ，リミテッド・ライアビリティ・カンパニー 疼痛治療に有用な化合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636194A (en) * 1969-10-23 1972-01-18 Douglas G Parizeau Composition and method for treating mastitis with therapeutic agents
DE2063896A1 (de) * 1970-12-28 1972-07-20 Dynamit Nobel Ag, 5210 Troisdorf Salbengrundlagen auf der Basis von Triglyceriden gesättigter mittelkettiger Fettsäuren und Verfahren zu deren Herstellung
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
RU2169143C2 (ru) * 1995-05-25 2001-06-20 Джи. Ди. Сирл Энд Ко. Способ получения 3-галогеналкил-1н-пиразолов
NZ309624A (en) * 1995-06-06 1999-04-29 Bayer Ag Non-irritating, non-sensitizing, non-ototoxic (harmful to the ears) antibacterial compositions
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
AP9700912A0 (en) * 1996-01-11 1997-01-31 Smithkline Beecham Corp Novel cycloalkyl substituted imidazoles
EP0892791B1 (en) * 1996-04-12 2003-03-05 G.D. Searle & Co. N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS
US5736151A (en) * 1996-12-09 1998-04-07 Pharmacia & Upjohn Company Antibiotic oil suspensions
US6307047B1 (en) * 1997-08-22 2001-10-23 Abbott Laboratories Prostaglandin endoperoxide H synthase biosynthesis inhibitors
US6440964B1 (en) * 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6395746B1 (en) * 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6509327B1 (en) * 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
US7064132B2 (en) * 1999-11-28 2006-06-20 Scientific Development And Research, Inc. Composition and method for treatment of otitis external
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
JP2003523958A (ja) * 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
US20010049366A1 (en) * 2000-02-09 2001-12-06 Alcon Universal Ltd. Topical solution formulations containing an antibiotic and a corticosteroid
WO2001072298A1 (en) * 2000-03-27 2001-10-04 The General Hospital Corporation Treatments for immune-mediated ear disorders
US20010053764A1 (en) * 2000-05-12 2001-12-20 Sims John E. Interleukin-1 inhibitors in the treatment of diseases
CA2409123A1 (en) * 2000-06-08 2001-12-13 The University Of Texas System Heterocycle derivatives and methods of use
WO2001098286A1 (en) * 2000-06-22 2001-12-27 Nitromed, Inc. Nitrosated and nitrosylated taxanes, compositions and methods of use
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions

Also Published As

Publication number Publication date
RU2005126363A (ru) 2006-05-10
BRPI0408559A (pt) 2006-03-21
RU2321423C2 (ru) 2008-04-10
TW200507852A (en) 2005-03-01
UY28236A1 (es) 2004-11-08
NZ541780A (en) 2008-06-30
WO2004082719A1 (en) 2004-09-30
JP2006520778A (ja) 2006-09-14
KR20050114245A (ko) 2005-12-05
NO20054777L (no) 2005-10-17
CA2519589A1 (en) 2004-09-30
CN1761486A (zh) 2006-04-19
US20040214753A1 (en) 2004-10-28
MXPA05010019A (es) 2005-11-17
KR100765614B1 (ko) 2007-10-09
EP1608406A1 (en) 2005-12-28
ZA200506531B (en) 2006-11-29
AU2004222518A1 (en) 2004-09-30
CO5611165A2 (es) 2006-02-28
TWI265809B (en) 2006-11-11
AR043651A1 (es) 2005-08-03

Similar Documents

Publication Publication Date Title
CL2004000471A1 (es) Composicion farmaceutica que comprende un agente antibacteriano y un segundo agente seleccionado de antiinflamatorios, analgesicos y antipireticos y un vehiculo que comprende un aceite anfipatico, cera microcristalina y un excipiente no acuoso; su us
FR2804025B1 (fr) Compositions pharmaceutiques stabilisees
DE60222898D1 (de) Orlistat und eine fettsäure oder eines ihrer salze enthaltende pharmazeutische zusammensetzung
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
NO20025450L (no) Ny farmasöytisk sammensetning
CL2007002678A1 (es) Composicion que comprende a) un primer agente seleccionado de loratadina, bifonazol, sertralina, ritonavir y atorvastatina, entre otros; y b) un segundo agente seleccionado de amprenavir, nevirapina y rosiglitazona, entre otros; kit farmaceutico, uti
NO20053987L (no) Flytende farmasoytiske palonosetronformuleringer
NO20033384D0 (no) Farmasöytisk formulering
BRPI0719182A2 (pt) Ácidos graxos omega 3 e agente dislipidêmico para redução de níveis de apo-b
ATE355271T1 (de) Pharmazeutische zusammensetzung
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
NO20033785D0 (no) Farmasöytisk formulering
DE60140462D1 (de) Darreichungsform zur hormonalen kontrazeption
ECSP045171A (es) Régimen de dosificación y composición farmacéutica para anticoncepción de emergencia
EE05020B1 (et) Glburiidi ravimkoostis
DE60006810D1 (de) Dicarboxylato-diamin-platin-derivate und zusammensetzungen die diese als antitumormittel enthalten
DE602004011398D1 (de) Direkt komprimierbare pharmazeutische zusammensetzung für die orale verabreichung von cci-779
DE60207595D1 (de) Stopfbuchse und diese enthaltende dichtungsvorrichtung
FI20022128A (fi) Farmaseuttinen koostumus
NO20021898L (no) Farmasoytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
NO20031095D0 (no) Farmasöytiske sammensetninger
BRPI0811629A2 (pt) Composição farmacêutica que compreende a combinação de um agente anti-inflamatório e um agente anticonvulsivo
ATE222586T1 (de) Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE60136923D1 (de) Auf öl basierende tintenzusammensetzung sowie dies